Literature DB >> 8826725

Barium enema preparation: a study of low-residue diet, "Picolax' and 'Kleen-Prep'.

S Hawkins1, P Bezuidenhout, P Shorvon, A Hine.   

Abstract

A prospective, randomized three-arm trial is presented of 150 consecutive patients attending for double-contrast barium enema (BE). This compares 'Picolax' (a combined stimulant and osmotic agent), 'Picolax' following a 3 day low-residue diet and 'Kleen-Prep' (a polyethylene-glycol osmotic agent). Faecal clearance, mucosal coating and colon fluid were scored in four colonic segments by two radiologists working independently and blinded to the preparation used. Analyses of an elderly subgroup and of side effects was performed. Low-residue diet conferred no benefit to Picolax preparation, which was satisfactory (ability to exclude 5 mm polyps) in 80% of patients. Kleen-Prep failed to achieve adequate preparation in 46%, due to excess fluid and poor mucosal coating. Kleen-Prep caused more patient nausea, abdominal bloating and pain than Picolax. Patients 70 years and older had similar results. Low-residue diet need not be used in addition to Picolax. Kleen-Prep as a single agent is not recommended for BE preparation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826725     DOI: 10.1111/j.1440-1673.1996.tb00393.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  3 in total

Review 1.  A review of current issues underlying colon cleansing before colonoscopy.

Authors:  Lawrence C Hookey; Stephen Vanner
Journal:  Can J Gastroenterol       Date:  2007-02       Impact factor: 3.522

2.  A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow?

Authors:  C J A Bowles; R Leicester; C Romaya; E Swarbrick; C B Williams; O Epstein
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 3.  Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser.

Authors:  Sheridan M Hoy; Lesley J Scott; Antona J Wagstaff
Journal:  Drugs       Date:  2009       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.